Document is current
Any future updates will be listed below
-
Authors
Feurstein, Simone https://orcid.org/0000-0002-9996-4277
Churpek, Jane E.
Walsh, Tom
Keel, Sioban
Hakkarainen, Marja https://orcid.org/0000-0003-3793-4803
Schroeder, Thomas
Germing, Ulrich
Geyh, Stefanie
Heuser, Michael https://orcid.org/0000-0001-5318-9044
Thol, Felicitas
Pohlkamp, Christian
Haferlach, Torsten
Gao, Juehua
Owen, Carolyn
Goehring, Gudrun
Schlegelberger, Brigitte
Verma, Divij
Krause, Daniela S. https://orcid.org/0000-0003-3603-1119
Gao, Guimin
Cronin, Tara
Gulsuner, Suleyman https://orcid.org/0000-0002-3897-1238
Lee, Ming
Pritchard, Colin C.
Subramanian, Hari Prasanna
del Gaudio, Daniela
Li, Zejuan
Das, Soma
Kilpivaara, Outi
Wartiovaara-Kautto, Ulla
Wang, Eunice S. https://orcid.org/0000-0002-8644-0968
Griffiths, Elizabeth A.
Döhner, Konstanze
Döhner, Hartmut
King, Mary-Claire
Godley, Lucy A. https://orcid.org/0000-0003-1914-9158
-
Funding
Funding for this research was provided by:
intramural ‘Baustein’ program for Junior Scientists of the Medical Faculty of Ulm University, Ulm, Germany
U.S. Department of Health & Human Services | National Institutes of Health (R03HL145253, R24DK099808, R35CA197458, R24DK099808, R24DK099808, P30CA016056, R35CA197458, R24DK099808)
U.S. Department of Health & Human Services | National Institutes of Health
Cancer Society of Finland, the Children’s Cancer Foundation Väre, and the Sigrid Juselius Foundation
German Bundesministerium für Bildung und Forschung ‘MyPred’
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
the Cancer Society of Finland, the Children’s Cancer Foundation Väre, and the Sigrid Juselius Foundation
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 26 August 2020
Revised: 17 December 2020
Accepted: 11 January 2021
First Online: 28 January 2021
Compliance with ethical standards
:
: We declare the following conflicts of interest: TW consults for Color Genomics. TH is part owner of the Munich Leukemia Laboratory. EAG has received honoraria/advisory board payments from Alexion Pharmaceuticals, Celgene/BMS, AbbVie, and Novartis. EAG has also received institutional research funding from Genentech Inc., Appelis pharmaceuticals, Celldex Therapeutics, and Celgene/BMS. CO has received honoraria/advisory board payments from AbbVie, AstraZeneca, Janssen, Roche, and Novartis. LAG and JEC have received honoraria from UptoDate, Inc. LAG has received advisory board payments from Invitae, Inc.
